In contrast, IFNβ-treated IFITKO peritoneal macrophages very efficiently controlled the infection, while IFNβ-treated cardiac fibroblasts showed an intermediate phenotype (Fig 3H & 3I) indicating that, for both of these cell types, other ISGs could wholly or partially restore antiviral resistance. This evidence concerns the gene IFNB1 and infection.